Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rhinocort Aqua Growth Study in Children
NCT00641212Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Jan 2000
- Primary completion
- Apr 2003
- Modality
- Orthosteric Ligands
01
Overview
Phase 4, randomised, double-blind trial in perennial allergic rhinitis (PAR) comparing Budesonide with Placebo (2 arms). Primary endpoint: Change in height over a 12 month period. Started Jan 2000; status: completed.
02
Drugs
budesonide
03
Conditions
perennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT00641212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00641212.